Indapamid MCC 1,5mg


1,5 mg indapamide

Pharmacological properties:

Slow release tablets, contain indapamide, a sulfonamide with reduced diuretic activity.


INDAPAMID MCC 1,5mg is indicated in treatment of essential arterial hypertension.


  •     hypersensitivity to indapamide, other sulfonamides or any of the product’s excipients.
  •     severe renal insufficiency
  •     hepatic encephalopathy or severe hepatic insufficiency
  •     hipokalemia

Side effects:

  •     Most of the adverse reactions are dose dependent. Thyazidic and related diuretics, including indapamide, can determine:
  •     Hepatic encephalopathy, in case of pre-existent hepatic insufficiency
  •     Hypersensitivity reactions, especially skin reactions, in patients with atopic history
  •     Macular and papular erruptions, purpura, the aggravation of pre-existentlupus erytematosus
  •     Rarely were spotted reactions of nausea, constipation, dry mouth, vertigo, fatigue, paresthesia and migraine. Generally, these symptoms disappear when the dose is reduced

Treatment and dosage:

According to doctor’s prescriptions.